search icon

    Market Snapshot

    • S&P Futures

      4,132.5

    • Dow Futures

      32,787

    • Nasdaq Futures

      13,107.75

    blog search icon

    Annexon, Inc.

    (NASDAQ:ANNX)

    $5.23

    $0.01

    0.19%

    Annexon, Inc. Chart

    ANNX Stock Price Today

    Annexon, Inc. (ANNX) stock rallied over 0.19% intraday to trade at $5.23 a share on NASDAQ. The stock opened with a gain of 4.81% at $5.24 and touched an intraday high of $5.33, rising 0.19% against the last close of $5.22. The stock went to a low of $5.1 during the session.

    Stock Snapshot

    $5.22

    Prev. Close

    194.35 Million

    Market Cap

    $5.1

    Day Low

    $5.24

    Open

    38.56 Million

    Number of Shares

    $5.33

    Day High

    -

    P/E ratio

    -3.63

    EPS (TTM)

    5.36

    Cash Flow per Share

    4.95

    Free Float in %

    6.89

    Book Value

    164,198

    Volume

    Annexon, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$5.24$5.33$5.1$5.23163,942
    2022-08-05$4.99$5.255$4.97$5.22226,300
    2022-08-04$5.05$5.11$4.91$5.0398,200
    2022-08-03$4.78$5.19$4.78$4.91181,600
    2022-08-02$4.52$4.738$4.52$4.6978,900
    2022-08-01$5.01$5.01$4.45$4.52304,100
    2022-07-29$5.21$5.21$4.88$5.01175,800
    2022-07-28$5.22$5.37$5.16$5.27129,700
    2022-07-27$5.15$5.22$4.95$5.19141,200
    2022-07-26$4.93$5.13$4.86$5.1196,300

    Contact Details

    1400 Sierra Point Parkway
    Building C Suite 200
    Brisbane, CA 94005
    United States

    Webiste:ANNX

    650 822 5500

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barre syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.

    Frequently Asked Questions

    icon

    What is the current Annexon, Inc. (ANNX) stock price?

    Annexon, Inc. (NASDAQ: ANNX) stock price is $5.23 as of the last check on Monday, August 8. During the trading session, ANNX stock reached the peak price of $5.33 while $5.1 was the lowest point it dropped to.

    icon

    ANNX's industry and sector of operation?

    The NASDAQ listed ANNX is part of Biotechnology industry that operates in the broader Health Care sector. Annexon, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders.

    icon

    Who are the executives of ANNX?

    Dr. Sanjay Keswani B.Sc., MBBS
    Exec. VP & Chief Medical Officer
    Mr. Douglas Love J.D., Esq.
    CEO, Pres & Director
    Dr. Larry C. Mattheakis Ph.D.
    Exec. VP & Chief Scientific Officer
    Dr. Ted Yednock Ph.D.
    Exec. VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board

    icon

    What is the ANNX stock price today?

    ANNX stock traded closed the last session at $5.23, which is $0.010000000000000675 or 0.19157088122606658% lower than its previous close of $5.22. ANNX's current trading price is 153.88% lower than its 52-week high of $23.61 where as its distance from 52-week low of 2.06% is -77.85%.

    icon

    How many employees does ANNX have?

    Number of ANNX employees currently stands at -. ANNX operates from 1400 Sierra Point Parkway, Building C Suite 200, Brisbane, CA 94005, United States.

    icon

    Link for ANNX official website?

    Official Webiste of $ANNX is: https://www.annexonbio.com

    icon

    How do I contact ANNX?

    ANNX could be contacted at ANNX operates from 1400 Sierra Point Parkway, Building C Suite 200, Brisbane, CA 94005, United States, or at phone #650 822 5500 and can also be accessed through its website.

    icon

    How many shares of ANNX are traded daily?

    ANNX stock volume for the day was 164,198 shares while in the previous session number of ANNX shares traded was 163,942 . The average number of ANNX shares traded daily for last 3 months was 452.82 Thousands.

    icon

    How much did ANNX change today?

    The percentage change in ANNX stock occurred in the recent session was 0.19157088122606658% while the dollar amount for the price change in ANNX stock was $0.010000000000000675.

    icon

    What price range ANNX stock been trading in?

    In the recent session, the day high for ANNX stock was $5.33 while the low for ANNX stock touched on the day was $5.1.

    icon

    What is the market cap of ANNX currently?

    The market value of ANNX currently stands at 194.35 Million with its latest stock price at $5.23 and 38.56 Million of its shares outstanding.